Latest Leverage News

BrainChip has launched its AKD2500 silicon development project, advancing its Akida™ 2.0 neuromorphic AI platform with a $2.5 million investment and prototype expected by Q3 2026.

Felix Gold Limited has confirmed significant extensions to gold mineralisation at its NW Array prospect in Alaska's Treasure Creek, with high-grade assay results and broad gold halos around antimony veins. The mineralised system remains open for further expansion, supporting the company's dual-commodity strategy.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

AuMEGA Metals has launched a C$10 million private placement to fund an extensive drilling program targeting high-potential gold and base metal prospects in Newfoundland’s Cape Ray District. The financing aims to unlock value from its significant mineral resources and strategic landholdings.

Metal Bank Limited has entered a non-binding MOU with Austral Resources to explore toll treatment of ore from the Millennium Project at Austral’s nearby Rocklands facility, aiming to advance a promising copper-cobalt-gold resource in NW Queensland.

Forrestania Resources has completed diamond drilling at its Lady Lila project and initiated drilling at British Hill, marking key steps in its strategy to build a multi-asset gold portfolio in Western Australia.

Regal Asian Investments Limited (ASX, RG8) reported a robust turnaround in its half-year results to 31 December 2025, posting a profit after tax of AUD 81.3 million and declaring a fully franked interim dividend of 8.0 cents per share.

PeopleIN Limited has appointed co-founder Tom Reardon as its new CEO and Managing Director, signaling continuity in leadership as the company reports a robust unaudited EBITDA of $16.1 million.

The CD Private Equity Fund Series reported robust performance in 2025, with improved exit activity and solid distributions despite currency headwinds. The funds continue to focus on asset-by-asset realisations while exploring portfolio liquidity options.

Osteopore Limited has secured an exclusive three-year distribution deal with Medprin Biotech GmbH to broaden its presence in Latin America's craniofacial reconstruction market, tapping into a region poised for significant growth.

Minbos Resources has appointed Rob Newbold as Acting CEO following the resignation of Lindsay Reed, while grappling with administrative and shareholder challenges delaying its key phosphate project in Angola.